Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing

Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing

Source: 
BioPharma Dive
snippet: 

Sandoz, the generic drug unit of Swiss pharma giant Novartis, plans to spend more than $175 million outfitting its European hub for antibiotics manufacturing with new technology.